Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $12.7500 (-0.31%) ($12.5900 - $13.0100) on Tue. May. 23, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.87% (three month average) | RSI | 34 | Latest Price | $12.7500(-0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -2.7% a day on average for past five trading days. | Weekly Trend | HALO declines -2.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.435% in a week (0% probabilities). VIXM(-13%) UUP(-9%) TLT(-6%) SHY(-4%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.435% (StdDev 2.87%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $13.85 | 5 Day Moving Average | $13.27(-3.92%) | 10 Day Moving Average | $13.68(-6.8%) | 20 Day Moving Average | $13.85(-7.94%) | To recent high | -13.1% | To recent low | 5.9% | Market Cap | $1.743b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |